Related Experiment Videos
T cell clonal anergy
1Laboratory of Cellular and Molecular Immunology, National Institutes of Health, Bethesda, MD 20892-0420, USA. rs34r@nih.gov
Current Opinion in Immunology
|June 1, 1997
Summary
Anergic T cells fail to produce IL-2 due to blocked signaling pathways and inhibitory molecules. Understanding these molecular mechanisms is key to restoring T cell function and immune responses.
Area of Science:
- Immunology
- Molecular Biology
- Cell Signaling
Background:
- T cell anergy is a state of unresponsiveness, often linked to impaired interleukin-2 (IL-2) gene transcription.
- IL-2 is crucial for T cell proliferation and immune response activation.
- Understanding the molecular basis of anergy is vital for immune system research.
Purpose of the Study:
- To elucidate the molecular mechanisms underlying the failure of anergic T cells to initiate IL-2 gene transcription after T cell receptor (TCR) stimulation.
- To identify specific molecular blocks and inhibitory factors contributing to T cell anergy.
Main Methods:
- Analysis of mitogen-activated protein kinase (MAPK) pathways, including ERK and JNK.
- Investigation of p21ras activation and its downstream effects on transcription factors.
- Characterization of repressor molecules involved in gene expression regulation.
Main Results:
- A block in the ERK and JNK MAPK pathways was identified, stemming from a failure in p21ras activation.
- Reduced induction of c-Fos and JunB proteins, leading to impaired activator protein (AP)-1 heterodimer formation and phosphorylation.
- Identification of repressor molecules, Nil-2-a and an AP-1-related molecule, that actively inhibit IL-2 gene transcription.
Conclusions:
- Two distinct molecular mechanisms contribute to the IL-2 transcription defect in anergic T cells.
- Impaired MAPK signaling and the action of dominant repressor molecules are critical factors in T cell anergy.
- These findings provide insights into potential targets for modulating T cell responses.